Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
BioMark Diagnostics Inc | 20B | Nov 14, 2024 | 0.15 | 0.00 |
Biomaxima SA | 944 | Nov 14, 2024 | 2.76 | -2.13 |
Biome Grow Inc | 6OTA | Nov 14, 2024 | 0.00 | 0.00 |
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A. | 6NQ | Nov 14, 2024 | 0.86 | -0.23 |
Biomerieux | EYWN | Nov 14, 2024 | 100.90 | -1.37 |
Biomind Labs Inc | 3XI | Nov 14, 2024 | 0.25 | -23.64 |
Bionomics ADR | B1N0 | Nov 14, 2024 | 0.18 | -10.55 |
BioNTech SE - American Depositary Shares | 22UA | Nov 14, 2024 | 99.00 | -7.65 |
BIONXT SOLUTIONS INC. | BXT | Nov 14, 2024 | 0.15 | -21.96 |
BioPharma Credit Plc | B3P | Nov 14, 2024 | 0.80 | 0.00 |
Biophytis | 6XB | Nov 14, 2024 | 0.00 | 0.00 |
BIOPHYTIS NAM. EO -,80 | 6XB3 | Nov 14, 2024 | 0.26 | -2.96 |
BioPorto | 2P4 | Nov 14, 2024 | 0.22 | -0.45 |
Biora Therapeutics | 4ZU0 | Nov 14, 2024 | 5.10 | 0.00 |
BioRestorative Therapies Inc | 9OF | Nov 14, 2024 | 1.28 | -17.95 |
Bioretec Oy | 0TN | Nov 14, 2024 | 1.85 | +1.65 |
Biosergen AB | 8N1 | Nov 14, 2024 | 0.05 | +2.75 |
Biosynex | 0DL | Nov 14, 2024 | 2.79 | -2.11 |
Biotage | PQX1 | Nov 14, 2024 | 13.73 | -0.51 |
Biotalys | 86C | Nov 14, 2024 | 2.89 | -1.03 |
Biotest AG | BIO3 | Nov 14, 2024 | 26.50 | -3.28 |
Biotest AG | BIO | Nov 14, 2024 | 41.00 | 0.00 |
Bioton S.A. | 7U5 | Nov 14, 2024 | 0.71 | +1.42 |
Bioventix Plc | 51B | Nov 14, 2024 | 46.40 | +0.87 |
Biovica International B | 9II | Nov 14, 2024 | 0.13 | +0.32 |
BioXcel Therapeutics, Inc. | BX2 | Nov 14, 2024 | 0.58 | -5.15 |
BIOXXMED AG INH O.N. KONV | T5O0 | Nov 14, 2024 | 2.53 | -16.50 |
Birchcliff Energy Ltd | 39B | Nov 14, 2024 | 3.42 | -0.49 |
Bird Construction Inc | 6LT | Nov 14, 2024 | 19.00 | -0.52 |
Bird River Resources Inc | 1Q1A | Nov 14, 2024 | 0.01 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.